Lineage Cell Therapeutics (LCTX) Assets Growth (1y) (2011 - 2026)
Lineage Cell Therapeutics (LCTX) Assets Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.99% |
| Dec 31, 2025 | -0.56% |
| Sep 30, 2025 | -7.20% |
| Jun 30, 2025 | -11.68% |
| Mar 31, 2025 | 3.01% |
| Dec 31, 2024 | 12.08% |
| Sep 30, 2024 | -9.00% |
| Jun 30, 2024 | -7.96% |
| Mar 31, 2024 | -4.17% |
| Dec 31, 2023 | -18.31% |
| Sep 30, 2023 | -19.06% |
| Jun 30, 2023 | -17.83% |
| Mar 31, 2023 | -21.67% |
| Dec 31, 2022 | -29.15% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | 0.87% |
| Mar 31, 2022 | 12.97% |
| Dec 31, 2021 | 61.69% |
| Sep 30, 2021 | 27.28% |
| Jun 30, 2021 | 20.23% |